Search

everythinglearnresearchcommunity

for

Search:↓

Estrogens and progesterones can help manage various health issues.

The document concludes that individualized treatment and lifestyle changes are important for managing menopause symptoms and health risks.

Weak endocrine disruptors in mixtures can have significant effects and should be considered in risk assessments.

Diane and Androcur 10 improved acne and seborrhea in most women, and hirsutism and alopecia in about half.

A postmenopausal woman's virilization was caused by a rare ovarian tumor that was hard to detect but was successfully treated with surgery.

Hormone-replacement therapy improved a woman's skin condition known as lymphomatoid papulosis.

Two new compounds were found to build bone and muscle without affecting reproductive organs and skin oil glands.

Some birth control pills can cause hair loss, and switching to ones with less androgen should help.

The document concludes that hirsutism can be managed with various treatments tailored to the individual, potentially improving quality of life.

Six months of treatment improved PCOS symptoms and reduced AMH levels.

Blocking androgen receptors early in life increases estrogen levels and reduces sexual motivation in male rats.

17α-estradiol lotion can reduce hair loss but doesn't promote new hair growth.

The document concludes that proper diagnosis and individualized treatment are crucial for managing androgenization in women effectively.

Eflornithine cream effectively reduces facial hair in women with hirsutism.

The medication combination did not affect glucose tolerance but increased some cholesterol levels due to its estrogen component.

Menopausal hormone therapy can improve skin and hair health in menopausal women.

Inhibiting testosterone 5alpha-reductase may help treat benign prostatic hyperplasia.

Taking cyproterone acetate and ethinyl oestradiol for hair loss can lower vitamin B12 levels in women.

A balanced approach using dutasteride and Serenoa repens can improve hair transplant success by protecting follicles and minimizing side effects.

Current and new treatments for hair loss include topical minoxidil and oral finasteride, but results vary and new options are being explored.

Scientists found new nonsteroidal compounds that can act like natural male hormones and might help treat male fertility and hormone issues.

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

Different halogens on progesterone derivatives can either block or mimic male hormone effects, depending on their type and amount.

Estrogen helps improve skin aging and healing, especially in post-menopausal women.

Dermatologists should guide transgender patients on effective hair growth and loss treatments during hormone therapy.

5-alpha reductase inhibitors and spironolactone don't increase gynecological tumor risk, glucagon-like-peptide-1 receptor agonists may increase alopecia risk, sanitary pads can cause dermatitis, early hidradenitis suppurativa intervention is crucial for Hispanic patients, community education boosts skin cancer awareness, metformin may improve skin cancer survival, LNG-IUDs can increase acne risk, machine learning accurately detects basal cell carcinoma, JAK-inhibitors may raise miscarriage risk, inclusive skincare ads affect those with darker skin, and CCCA in Black women might involve autoimmunity.

Testosterone reduces knee movement, while flutamide and finasteride increase it.

Cyproterone acetate implants were more effective at reducing facial hair and improving skin in severe hirsutism than oral treatment.

New steroid compounds may help with hormonal therapy and have potential benefits for glucose disorders, but more research is needed.